Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IceCure Medical Ltd. - Ordinary Shares (NQ:ICCM)

0.6173 -0.0227 (-3.55%)
Streaming Delayed Price Updated: 11:59 AM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IceCure Medical Ltd. - Ordinary Shares

< Previous 1 2 3 4 Next >
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
IceCure Medical Ltd (NASDAQ:ICCM) Tops Q3 2025 Revenue Estimates ↗
IceCure Medical (ICCM) beat Q3 2025 revenue estimates by 17%, driven by its FDA-authorized ProSense system for breast cancer treatment. 
Via Chartmill
News headline image
Earnings Scheduled For November 19, 2025 ↗
 
Via Benzinga
IceCure Medical’s Treatment For Low-Risk Breast Cancer In Women Aged 70 And Over Receives FDA Approval ↗
Via Stocktwits
News headline image
Examining the Future: Icecure Medical's Earnings Outlook ↗
 
Via Benzinga
News headline image
Earnings Preview For Icecure Medical ↗
 
Via Benzinga
News headline image
What's Next: Icecure Medical's Earnings Preview ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
The market is filled with gapping stocks in Thursday's session. ↗
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Outlook For Icecure Medical ↗
 
Via Benzinga
News headline image
Icecure Medical Earnings Review: Q3 Summary ↗
 
Via Benzinga
News headline image
What to Expect from Icecure Medical's Earnings ↗
 
Via Benzinga
News headline image
IceCure Medical Advances FDA Review ↗
Via The Motley Fool
News headline image
IceCure (ICCM) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
IceCure (ICCM) Q1 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Earnings Scheduled For May 28, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 13, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 27, 2025 ↗
 
Via Benzinga
News headline image
Which stocks are gapping on Thursday? ↗
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
News headline image
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
Earnings Scheduled For November 26, 2024 ↗
 
Via Benzinga
News headline image
ICCM Stock Earnings: Icecure Medical Beats EPS, Beats Revenue for Q2 2024 ↗
ICCM stock results show that Icecure Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
We have all of the biggest pre-market stock movers that investors are going to want to keep an eye on for Monday morning! 
Via InvestorPlace
News headline image
ICCM Stock Earnings: Icecure Medical Meets EPS, Misses Revenue for Q1 2024 ↗
ICCM stock results show that Icecure Medical met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
New Standard of Care? IceCure Submits Final ICE3 Data To FDA, Minimally Invasive Cryoablation Shows Similar 5-year Recurrence Outcomes To Surgery With Hormone Therapy
New Standard of Care? IceCure Submits Final ICE3 Data To FDA, Minimally Invasive Cryoablation Shows Similar 5-year Recurrence Outcomes To Surgery With Hormone Therapy 
Via News Direct
News headline image
Game-Changing Tumor Freezing Technology Has The Potential To Offer Women First-Ever Minimally Invasive Alternative To Breast Lumpectomy Surgery
Game-Changing Tumor Freezing Technology Has The Potential To Offer Women First-Ever Minimally Invasive Alternative To Breast Lumpectomy Surgery 
Via News Direct
News headline image
ICCM Stock Earnings: Icecure Medical Meets EPS, Beats Revenue for Q4 2023 ↗
ICCM stock results show that Icecure Medical met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Earnings Scheduled For April 3, 2024 ↗
Companies Reporting Before The Bell • Acuity Brands (NYSE:AYI) is projected to report quarterly earnings at $3.25 per share on revenue of $907.75 million. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.